AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, is expanding the scope and ...
Isotopes Market There is an increasing trend in the use of rare stable isotopes, such as 13C, 15N, and 18O, as tracers in scientific resear ...
Australian clinical-stage radiopharmaceutical company AdvanCell has announced an expansion to the scope and breadth of its ...
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an expansion to the scope and breadth of its strategic collaboration with Eli Lilly ...
Efforts will be made to urgently complete and develop the national nuclear power infrastructure to support the implementation ...
Given the shared vision for clean energy and nuclear security, India and France can play a pivotal role in ensuring global ...
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an expansion to the scope and breadth of its strategic collaboration with Eli Lilly ...
Interesting Engineering on MSN6d
Desk-sized fusion reactors could solve medical isotope crisis for cancer diagnosisFusion-powered isotope supply. Medical isotopes are radioactive substances essential for diagnosing and treating serious diseases. They emit radiation that can be detected and ana ...
Ambar Arbud Sewa, in collaboration with Meta Healthcare Nepal, United Imaging Healthcare, and Longevous BeamTech Co Ltd ...
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in Oppenheimer’s 35 th Annual Healthcare Life Sciences Conference. Dr. Andrew ...
Read on to learn more about the six Australian and New Zealand startups that raised $234.2 million in the legal, healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback